Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 20.11
+0.82 (4.25%)
Sep 30, 2026, 3:04 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 11.97 billion as of October 2, 2026. Its market cap has increased by 16.38% in one year.
Market Cap
11.97B
Enterprise Value
8.90B
Revenue
1.19B
Ranking
n/a
PE Ratio
60.33
Stock Price
20.11
ChartMarket Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 11.97B, a decrease of -57.45%. That is a compound annual growth rate of -16.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 11.97B | 7.94% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 14.16B |
| Nanjing Vazyme Biotech | 14.08B |
| Jinyu Bio-technology | 12.65B |
| Chengdu Olymvax Biopharmaceuticals | 12.65B |
| Inner Mongolia Furui Medical Science | 12.44B |
| Mabwell (Shanghai) Bioscience | 11.61B |
| Shanghai OPM Biosciences | 11.32B |
| Novoprotein Scientific | 11.15B |